Conrad Russell Y Cruz | Assistant Professor, Children's National Medical Center; Co-Founder
Children's National Medical Center

Conrad Russell Y Cruz, Assistant Professor, Children's National Medical Center; Co-Founder, Children's National Medical Center

Dr. Cruz is developing immune cell-based therapies for cancer and HIV. His work is focused on T cells and NK cells – experimentally tractable cells of the adaptive and innate immune response, respectively, that have been used in the clinics. His laboratory is focused on different ways of developing these T cells - genetic modification, ex vivo expansion, and combination with current chemotherapies. He is currently an Assistant Professor of Pediatrics at Children's National Medical Center/The George Washington University and helps lead the Translational Research Laboratories of the newly established Program for Cell Enhancement and Technologies for Immunotherapy (CETI) at Children’s National Medical Center/The George Washington University in Washington, DC.

Appearances:



Conference Day 2 - Wednesday 1st April 2020 @ 14:40

Engineering NK Cell Resistance to the Tumor Microenvironment

  • Role of TME-mediated immune suppression in tumor progression and its negative effects on NK cell function
  • Engineering NK cell resistance to TGF-beta
  • In vitro and in vivo function of gene modified NK cells
last published: 04/Jun/20 08:25 GMT

back to speakers